Business Wire

MILREM-ROBOTICS

4.9.2019 08:02:09 CEST | Business Wire | Press release

Share
Milrem Robotics’ THeMIS UGV passes air transportability tests

The THeMIS unmanned ground vehicle (UGV) by Milrem Robotics, the leading European UGV manufacturer and developer of robotic warfare solutions, passes air transportability tests that adds one more option for it to be deployed to operation areas.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190903005432/en/

“The most common question about THeMIS size class unmanned ground vehicles is how do you get them to where you need to use them,” explained Kuldar Väärsi, CEO of Milrem Robotics. “We have tackled this question during development of the newest – fifth generation THeMIS - and added a number of options: towing, hauling, following a convoy autonomously and now airlifting,” Väärsi added.

The air transportability tests were conducted according to NATO standard STANAG 3542 and was facilitated by the helicopter crew of the Estonian Police and Border Guard.

The THeMIS is a multipurpose tracked vehicle that can be equipped with other warfighting technology such as weapon systems, tethered drones, IED detection devices and much more. It can carry a payload of up to 1200kg, move 25 km/h and pull other equipment with a force of 21 000 N.

The THeMIS can be remotely operated via cameras or using autonomous functions such as waypoint navigation, follow-me etc. The intention is to keep soldiers safe, increase their capabilities and in addition lighten their load.

Thanks to the systems modularity it has become a very popular choice for different payload integrations and Milrem Robotics has already integrated a dozen different systems with industry partners like Kongsberg, FN Herstal, MBDA, ST Engineering etc.

Please have a look at the THeMIS’ air transportability tests here - https://youtu.be/t6Gf7tBf0qw

The THeMIS will be exhibited at DSEI in London from September 10 to 13 and can be found in the following locations:

  • At the Estonian Pavilion (N3-320) where we will be unveiling the fifth generation THeMIS UGV. The UGV will be equipped with FN Herstal’s deFNder® Medium RWS;
  • At Kongsberg’s stand (S6-145) where another fifth generation THeMIS will be displayed equipped with Kongsberg’s PROTECTOR RWS-LW30;
  • At the Land Ceptor Stand (N10-260) where we will be unveiling a new integration project with MBDA – the THeMIS with the Brimstone ultra-high precision missile system;
  • At QinetiQ’s stand (S3-400) another force multiplier will be exhibited.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release

Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and

Huawei, LG Electronics and Nokia Named as Founder Licensors of New Sisvel POS Pool1.4.2026 12:17:00 CEST | Press release

Three world-class innovators are the founder licensors of the new Point of Sale (POS) patent pool, covering 2G to 5G technology, which Sisvel has launched today. Huawei, LG Electronics and Nokia have made their standard essential patents (SEPs) reading on cellularly connected POS devices available through the programme, so simplifying access to the increasingly ubiquitous technology. Early participation incentives for licensors to join the pool are available until mid-May. Other cellular patent owners not currently in discussions with Sisvel are encouraged to get in touch. Ranging from handheld card machines to tablet-based registers, POS devices have transformed customer payment processing. Increasingly, they also offer enhanced capabilities such as inventory management, real-time tracking, advanced analytics and automatic re-ordering. Standardised cellular technology is the critical feature that enables POS terminals to function wherever customers are located. The Sisvel POS programm

Mosaic Therapeutics appoints Dr Vince O'Neill, MD, as Head of R&D1.4.2026 11:11:00 CEST | Press release

- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic’s Executive Leadership team - Vince will lead research and development for Mosaic’s drug combination programs, including the build-out of the Company’s early pipeline Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O’Neill as Head of Research and Development (R&D) to support its next phase of growth. “We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company’s evolution,”said Thomas Fuchs, CEO, Mosaic Therapeutics.“His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.” Vince is a board-certified medical oncologist and highly experienced biotechno

The AI Summit London Launches Strategic Partnerships with London Business School and General Purpose to Ignite New Era in AI Leadership1.4.2026 09:00:00 CEST | Press release

New One-Day Intensive Experience Offered 9 June Ahead of Conference 10-11 June at Tobacco Dock Featuring 10 Stages and 14 Tracks The AI Summit London, the conference where commercial AI comes to life, has announced strategic collaborations with London Business School and General Purpose to introduce two dedicated AI Training programmes, taking place ahead of the conference on 9 June. Drawing upon the globally recognised expertise in executive education at the London Business School’s Data Science & AI Initiative (DSAI), the one-day AI Leadership Accelerator is a high-impact session designed to equip senior business leaders with the knowledge and tools to unlock real and profitable value from AI. The DSAI at London Business School helps leaders make sense of AI in a way that goes beyond the hype, focusing on what it really means for their organisations, industries, and competitive positioning. Drawing on rigorous, cross-disciplinary research, DSAI provides clear, evidence-based insights

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye